The ASX 200 added 45 points or 0.76% to 5964.2 on Monday. Market sentiment was optimistic after Gilead Sciences said its coronavirus treatment candidate, Remdesivir, showed an improvement in clinical recovery and a 62% reduction in the risk of mortality. However, optimism was limited as Victoria continues to struggle with community transmission of the novel coronavirus, while fresh clusters emerge in neighboring New South Wales. The news follows the World Health Organisation’s report of a record increase in global coronavirus cases - the total rising by 230,370 in 24 hours, with the biggest increases seen in United States, Brazil, India and South Africa.
Learn more about your ad choices. Visit megaphone.fm/adchoices